Case number 1:17-cv-01639
AstraZeneca LP et al v. Prinston Pharmaceutical Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 3, 2019 | 15 | Patent/Trademark Report to Commissioner (1) |
| Jan 3, 2019 | 15 | Consent Judgment (4) |
| Jan 3, 2019 | 15 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,251,910; RE46,276; 7,250,419; 7,265,124. (Attachments: # (1) Consent Judgment)(nms) |
| Jan 2, 2019 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per D.I. [14]. (nms) |
| Jan 2, 2019 | 14 | Consent Judgment (4) Docket Text: CONSENT JUDGMENT between AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Prinston Pharmaceutical Inc.. Signed by Judge Richard G. Andrews on 1/2/2019. Associated Cases: 1:15-cv-01000-RGA, 1:17-cv-01639-RGA(nms) |
| Dec 21, 2018 | 13 | Proposed Consent Judgment (4) Docket Text: PROPOSED Consent Judgment, by AstraZeneca AB, AstraZeneca LP, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Silver, Daniel) Modified on 12/28/2018 (nms). |
| Jan 11, 2018 | 12 | Order Administratively Closing Case (1) Docket Text: ORDER Administratively Closing Case (see Order for further details). Signed by Judge Richard G. Andrews on 1/11/2018. (nms) |
| Dec 19, 2017 | 11 | Order (7) Docket Text: SO ORDERED Granting [10] Stipulation and Order Staying Prinston Action. Signed by Judge Richard G. Andrews on 12/19/2017. (nms) |
| Dec 18, 2017 | 10 | Stipulation (7) Docket Text: STIPULATION and Proposed Order Staying Prinston Action, by AstraZeneca AB, AstraZeneca LP, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (nms) |
| Nov 17, 2017 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf for D.I. [9] has been replaced per counsel's request. The signed and dated version of the document has replaced the unexecuted one. (nms) |
| Nov 17, 2017 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by AstraZeneca LP, AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca AB: For Prinston Pharmaceutical Inc. waiver sent on 11/13/2017, answer due 1/12/2018. (Silver, Daniel) (Main Document 9 replaced on 11/17/2017) (nms). |
| Nov 15, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Nov 13, 2017 | 1 | Complaint (12) |
| Nov 13, 2017 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (nmfn) |
| Nov 13, 2017 | 1 | Exhibits A-E (120) |
| Nov 13, 2017 | 1 | Civil Cover Sheet (2) |
| Nov 13, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmfn) |
| Nov 13, 2017 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/1/2017. Date of Expiration of ('910) Patent: 7/15/2018. Thirty Month Stay Deadline: 5/1/2020. SEE ANDA FORM for the expiration dates of the three remaining patents-in-suit.(nmfn) |
| Nov 13, 2017 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,251,910; RE46,276; 7,250,419; 7,265,124. (nmfn) |
| Nov 13, 2017 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca LP filed by AstraZeneca LP. (nmfn) |
| Nov 13, 2017 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB filed by AstraZeneca AB. (nmfn) |
| Nov 13, 2017 | 7 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca Pharmaceuticals LP filed by AstraZeneca Pharmaceuticals LP. (nmfn) |
| Nov 13, 2017 | 8 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca UK Limited filed by AstraZeneca UK Limited. (nmfn) |
| Nov 13, 2017 | 1 | Main Document (12) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Prinston Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2264973.) - filed by AstraZeneca LP, AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca AB. (Attachments: # (1) Exhibits A-E, # (2) Civil Cover Sheet)(nmfn) |
| Nov 13, 2017 | 1 | Complaint* (1) |
